India's Pharmaceutical Exports

Country Profile

Bolivia

Bolivia is an emerging destination for Indian pharmaceutical exports — $25.1M in FY 2025–26, with 2.6× growth over the past decade. Medicines accounts for 76% of shipments, with vaccines contributing $4.19M. The compound annual growth rate since FY2015 stands at 9.1%.

🇧🇴 $25.1M · 2.6× growth since FY2015 · 9.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$25.1M
Exports FY2025–26 DGCIS
2.6×
Growth FY2015→2026
9.1%
CAGR FY2015→2026
76%
Medicines Share
5
Product Categories Supplied
Bolivia is an emerging destination for Indian pharmaceutical exports — $25.1M in FY 2025–26, with 2.6× growth over the past decade. Medicines accounts for 76% of shipments, with vaccines contributing $4.19M. The compound annual growth rate since FY2015 stands at 9.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $19.0M (75.6%) Vaccines $4.19M (16.7%) Medicine Ingredients $1.38M (5.5%) Surgical & Hospital Supplies $561K (2.2%) Traditional & Herbal $6K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Bolivia in the RBI overseas direct investment dataset (2011–2026).